Stem cell therapy for pelvic organ prolapse
Pelvic organ prolapse—POP—is a hidden disease. While the injury happens during childbirth, the patient may not know about the damage […]
» Read moreCryopreservation, or the long-term storage of biomaterials at ultralow temperatures, has been used across cell types and species. However, until […] Scientific advances in cancer research and new means of diagnosis and treatment have made it possible to cure many patients. […] Using a widely known field of mathematics designed mainly to study how digital and other forms of information are measured, […] Cancer has been the focus much research in the biomedical fields. Today, with research methods advancing rapidly and the base […] People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune […] Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with a high fatality rate. Currently, chemotherapy is the […] A new source of energy expending brown fat cells has been uncovered by researchers at the Joslin Diabetes Center, which […] In order to study a wide variety of biological processes, understanding cellular invasion and migration is crucial. Researchers can investigate […] University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-CoV-2-;the virus that causes […]
First-of-its-kind method cryopreserves fruit fly embryos in liquid nitrogen
Hypoxia radioactive marker will detect aggressiveness of tumors, eliminating the need for biopsy
Field of mathematics reveals a potential gene that causes acute lymphoblastic leukemia
Unlocking new avenues for curing cancer: Cell receptor neuropilin-1 could hold the key
Recovered COVID-19 patients may need only a single vaccine dose, suggests study
CityU researchers identify super-enhancers that stimulate the activity of breast cancer genes
Researchers uncover a new source of energy expending brown fat cells
Researching Cell Migration Assay Applications
FDA-approved cancer drug blunts SARS-CoV-2 protein's detrimental effects
